Stock RVLPQ RVL PHARMACEUTICALS PLC
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases RVL Pharmaceuticals plc

Equities

RVLPQ

IE00BF2HDL56

Market Closed - OTC Markets
Other stock markets
 20:25:18 17/06/2024 BST 		5-day change 1st Jan Change
0.000001 USD 0.00% Intraday chart for RVL Pharmaceuticals plc 0.00% 0.00%
04-12 North American Morning Briefing : Big Banks Kick -2- DJ
03-21 North American Morning Briefing : Investors -2- DJ

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
RVL Pharmaceuticals - Upneeq Wins 2024 Shape Skin Award, 'Best for Lift', in the Professional Treatment Category
AQ
Thinking about buying stock in Sterling Infrastructure, Mereo BioPharma Group, RVL Pharmaceuticals, SeaStar Medical Holding, or Harpoon Therapeutics?
PR
RVL Pharmaceuticals plc Announces Prepackaged Reorganization of Certain U.S. Subsidiaries
AQ
Thinking about buying stock in Camber Energy, RVL Pharmaceuticals, Longeveron, Better Choice Company, or Beneficient?
PR
Thinking about buying stock in Femasys, micromobility.com, RVL Pharmaceuticals, SeaStar Medical Holding, or Cantaloupe Inc?
PR
Thinking about buying stock in OpGen Inc, SeaStar Medical Holding, RVL Pharmaceuticals, Terawulf Inc, or Bitfarms Ltd?
PR
RVL Pharmaceuticals : Regulation FD Disclosure - Form 8-K
PU
RVL Pharmaceuticals plc to Present at the H.C. Wainwright 25th Annual Global Investment Conference
AQ
RVL Pharmaceuticals plc Announces $5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
AQ
RVL Pharmaceuticals plc Reports Second Quarter 2023 Financial Results; Provides Update on Strategic Business Review
AQ
RVL Pharmaceuticals plc to Discuss Second Quarter 2023 Financial Results and Provide Commercial Update
AQ
RVL Pharmaceuticals plc Provides Business Update
AQ
RVL Pharmaceuticals plc Announces Result of Proposal to Approve a Waiver of Offer Obligations under Rule 9 of the Irish Takeover Rules at Annual General Meeting
AQ
RVL Pharmaceuticals : 2022 Irish Statutory Financial Statements
PU
RVL Pharmaceuticals : Corporate Presentation May 2023
PU
RVL PHARMACEUTICALS PLC : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)
AQ
RVL Pharmaceuticals plc Reports First Quarter 2023 Financial Results; Provides Commercial Update
AQ
RVL Pharmaceuticals plc to Discuss First Quarter 2023 Financial Results and Provide Commercial Update
AQ
RVL Pharmaceuticals : Corporate Presentation April 2023
PU
RVL Pharmaceuticals Announces that Upneeq® Wins “Best Eye Drop for Drooping Lids” NewBeauty in 13th Annual Beauty Awards
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RVLPQ Stock
  4. News RVL Pharmaceuticals plc
  5. Press Releases